Tango Therapeutics, Inc. (TNGX)

NASDAQ: TNGX · Real-Time Price · USD

19.42

+0.10 (0.52%)

At close: Mar 20, 2026, 4:00 PM EDT

19.31

-0.11 (-0.57%)

After-hours: Mar 20, 2026, 6:31 PM EDT

Tango Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	112.28	69.53	66.39	59.97	142.75
Short-Term Investments	230.86	188.39	270.5	306.17	342.51
Cash & Short-Term Investments	343.14	257.92	336.89	366.13	485.26
Cash Growth	33.04%	-23.44%	-7.99%	-24.55%	154.97%
Accounts Receivable	-	-	-	2	2
Other Current Assets	10.62	8.43	9.65	7.14	5.08
Total Current Assets	353.76	266.34	346.54	375.27	492.34
Net Property, Plant & Equipment	42.49	47.58	53.42	57.77	6.09
Other Long-Term Assets	2.44	2.57	2.61	3.43	1.73
Total Assets	398.69	316.49	402.57	436.47	500.16
Accounts Payable	1.18	1.6	2.79	4.45	3.23
Accrued Expenses	17.76	16.5	15.4	17.5	9.89
Current Portion of Leases	2.74	2.45	2.08	1.77	1.5
Unearned Revenue	-	17.62	25.67	31.79	26.02
Other Current Liabilities	-	-	-	0.04	0.05
Total Current Liabilities	21.68	38.17	45.94	55.55	40.69
Long-Term Leases	30.83	34.04	36.84	39.36	-
Other Long-Term Liabilities	-	44.77	66.68	92.09	114.72
Total Long-Term Liabilities	30.83	78.81	103.52	131.45	114.72
Total Liabilities	52.51	116.98	149.46	186.99	155.41
Common Stock	0.14	0.11	0	0.09	0.09
Additional Paid-in Capital	948.97	700.63	624.08	522.61	506.76
Accumulated Other Comprehensive Income	0.22	0.34	0.19	-3.71	-0.77
Retained Earnings	-603.15	-501.56	-371.26	-269.51	-161.34
Total Common Shareholders' Equity	346.18	199.52	253.11	249.48	344.75
Shareholders' Equity	346.18	199.52	253.01	249.48	344.75
Total Liabilities & Equity	398.69	316.49	402.57	436.47	500.16
Total Debt	33.57	36.49	38.92	41.13	1.5
Net Cash (Debt)	309.57	221.42	297.97	325	483.75
Net Cash Growth	39.81%	-25.69%	-8.32%	-32.82%	165.16%
Net Cash Per Share	2.67	2.03	3.15	3.70	7.79
Book Value	346.18	199.52	253.11	249.48	344.75
Book Value Per Share	2.98	1.83	2.68	2.84	5.55
Tangible Book Value	346.18	199.52	253.11	249.48	344.75
Tangible Book Value Per Share	2.98	1.83	2.68	2.84	5.55

Updated Mar 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q